Global Immunoprotein Diagnostic Testing Market to Reach $20.3 Billion by 2030
The global market for Immunoprotein Diagnostic Testing estimated at US$13.5 Billion in the year 2022, is projected to reach a revised size of US$20.3 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2022-2030. Immunoglobulin Diagnostic, one of the segments analyzed in the report, is projected to record 6% CAGR and reach US$5.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Free Light Chain Diagnostic segment is readjusted to a revised 4.2% CAGR for the next 8-year period.The U.S. Market is Estimated at $4 Billion, While China is Forecast to Grow at 4.8% CAGR
The Immunoprotein Diagnostic Testing market in the U.S. is estimated at US$4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.Select Competitors (Total 38 Featured) -
- Abbott Laboratories
- Abcam PLC
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin SpA
- Enzo Biochem, Inc.
- F. Hoffmann-La Roche AG
- Ortho Clinical Diagnostics
- Siemens AG
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Abcam PLC
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin SpA
- Enzo Biochem, Inc.
- F. Hoffmann-La Roche AG
- Ortho Clinical Diagnostics
- Siemens AG
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 171 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 13.5 Billion |
Forecasted Market Value ( USD | $ 20.3 Billion |
Compound Annual Growth Rate | 5.2% |
Regions Covered | Global |